277 related articles for article (PubMed ID: 25534917)
1. The effect of warfarin therapy on breast, colorectal, lung, and prostate cancer survival: a population-based cohort study using the Clinical Practice Research Datalink.
O'Rorke MA; Murray LJ; Hughes CM; Cantwell MM; Cardwell CR
Cancer Causes Control; 2015 Mar; 26(3):355-66. PubMed ID: 25534917
[TBL] [Abstract][Full Text] [Related]
2. Clopidogrel use and cancer-specific mortality: a population-based cohort study of colorectal, breast and prostate cancer patients.
Hicks BM; Murray LJ; Hughes C; Cardwell CR
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):830-40. PubMed ID: 26017274
[TBL] [Abstract][Full Text] [Related]
3. Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts.
Cardwell CR; Mc Menamin ÚC; Hicks BM; Hughes C; Cantwell MM; Murray LJ
BMC Med; 2014 Feb; 12():28. PubMed ID: 24521426
[TBL] [Abstract][Full Text] [Related]
4. Neighborhood and Individual Socioeconomic Disadvantage and Survival Among Patients With Nonmetastatic Common Cancers.
Cheng E; Soulos PR; Irwin ML; Cespedes Feliciano EM; Presley CJ; Fuchs CS; Meyerhardt JA; Gross CP
JAMA Netw Open; 2021 Dec; 4(12):e2139593. PubMed ID: 34919133
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic intervals and its association with breast, prostate, lung and colorectal cancer survival in England: historical cohort study using the Clinical Practice Research Datalink.
Redaniel MT; Martin RM; Ridd MJ; Wade J; Jeffreys M
PLoS One; 2015; 10(5):e0126608. PubMed ID: 25933397
[TBL] [Abstract][Full Text] [Related]
6. Low-dose aspirin use and cancer characteristics: a population-based cohort study.
Jonsson F; Yin L; Lundholm C; Smedby KE; Czene K; Pawitan Y
Br J Cancer; 2013 Oct; 109(7):1921-5. PubMed ID: 23887604
[TBL] [Abstract][Full Text] [Related]
7. Disparities in Prostate, Lung, Breast, and Colorectal Cancer Survival and Comorbidity Status among Urban American Indians and Alaskan Natives.
Emerson MA; Banegas MP; Chawla N; Achacoso N; Alexeeff SE; Adams AS; Habel LA
Cancer Res; 2017 Dec; 77(23):6770-6776. PubMed ID: 29187399
[TBL] [Abstract][Full Text] [Related]
8. Pre- and Post-diagnosis Diabetes as a Risk Factor for All-Cause and Cancer-Specific Mortality in Breast, Prostate, and Colorectal Cancer Survivors: a Prospective Cohort Study.
Tao H; O'Neil A; Choi Y; Wang W; Wang J; Wang Y; Jia Y; Chen X
Front Endocrinol (Lausanne); 2020; 11():60. PubMed ID: 32132977
[No Abstract] [Full Text] [Related]
9. The Use of Telmisartan and the Incidence of Cancer.
Tascilar K; Azoulay L; Dell'Aniello S; Bartels DB; Suissa S
Am J Hypertens; 2016 Dec; 29(12):1358-1365. PubMed ID: 27557862
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulants and cancer mortality in the Finnish randomized study of screening for prostate cancer.
Kinnunen PTT; Murtola TJ; Talala K; Taari K; Tammela TLJ; Auvinen A
Cancer Causes Control; 2019 Aug; 30(8):877-888. PubMed ID: 31209595
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive medications and survival in patients with cancer: a population-based retrospective cohort study.
Holmes S; Griffith EJ; Musto G; Minuk GY
Cancer Epidemiol; 2013 Dec; 37(6):881-5. PubMed ID: 24075077
[TBL] [Abstract][Full Text] [Related]
12. Mortality in Incident Maintenance Dialysis Patients Versus Incident Solid Organ Cancer Patients: A Population-Based Cohort.
Naylor KL; Kim SJ; McArthur E; Garg AX; McCallum MK; Knoll GA
Am J Kidney Dis; 2019 Jun; 73(6):765-776. PubMed ID: 30738630
[TBL] [Abstract][Full Text] [Related]
13. The role of comorbidities on the uptake of systemic treatment and 3-year survival in older cancer patients.
Stavrou EP; Lu CY; Buckley N; Pearson S
Ann Oncol; 2012 Sep; 23(9):2422-2428. PubMed ID: 22351742
[TBL] [Abstract][Full Text] [Related]
14. Overall and cancer-specific survival of patients with breast, colon, kidney, and lung cancers with and without chronic lymphocytic leukemia: a SEER population-based study.
Solomon BM; Rabe KG; Slager SL; Brewer JD; Cerhan JR; Shanafelt TD
J Clin Oncol; 2013 Mar; 31(7):930-7. PubMed ID: 23341508
[TBL] [Abstract][Full Text] [Related]
15. Serum total thiol levels and the risk of lung, colorectal, breast and prostate cancer: A prospective case-cohort study.
Gào X; Wilsgaard T; Jansen EHJM; Xuan Y; Anusruti A; Brenner H; Schöttker B
Int J Cancer; 2020 Mar; 146(5):1261-1267. PubMed ID: 31125113
[TBL] [Abstract][Full Text] [Related]
16. β-Blocker usage and colorectal cancer mortality: a nested case-control study in the UK Clinical Practice Research Datalink cohort.
Hicks BM; Murray LJ; Powe DG; Hughes CM; Cardwell CR
Ann Oncol; 2013 Dec; 24(12):3100-6. PubMed ID: 24050955
[TBL] [Abstract][Full Text] [Related]
17. Racial/ethnic disparities in de novo metastases sites and survival outcomes for patients with primary breast, colorectal, and prostate cancer.
Akinyemiju T; Sakhuja S; Waterbor J; Pisu M; Altekruse SF
Cancer Med; 2018 Apr; 7(4):1183-1193. PubMed ID: 29479835
[TBL] [Abstract][Full Text] [Related]
18. Lipid-Lowering Drug Use and Cancer Incidence and Mortality in the ARIC Study.
Marrone MT; Mondul AM; Prizment AE; Couper D; Barber JR; Chappidi MR; Joshu CE; Platz EA
JNCI Cancer Spectr; 2021 Oct; 5(5):. PubMed ID: 34738072
[TBL] [Abstract][Full Text] [Related]
19. Association of Aspirin Use With Mortality Risk Among Older Adult Participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Loomans-Kropp HA; Pinsky P; Cao Y; Chan AT; Umar A
JAMA Netw Open; 2019 Dec; 2(12):e1916729. PubMed ID: 31800071
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of preexisting diabetes mellitus in breast, colorectal, and prostate cancer.
Griffiths RI; Valderas JM; McFadden EC; Bankhead CR; Lavery BA; Khan NF; Stevens RJ; Keating NL
J Cancer Surviv; 2017 Oct; 11(5):604-613. PubMed ID: 28735467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]